Evidence map›Paper›PMID 25935214›Full record

Trial reportAIDS and behavior2015

Assessment of contamination and misclassification biases in a randomized controlled trial of a social network peer education intervention to reduce HIV risk behaviors among drug users and risk partners in Philadelphia, PA and Chiang Mai, Thailand.

Nicole Simmons, Deborah Donnell, San-San Ou, David D Celentano, Apinun Aramrattana, Annet Davis-Vogel, David Metzger, Carl Latkin

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. HIV prevention intervention for substance users: a review of the literature.Substance abuse treatment, prevention, and policy · 2019
    Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nicole SimmonsDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Deborah DonnellStatistical Center for HIV/AIDS Research and Prevention (SCHARP), Seattle, WA, USA.
San-San OuStatistical Center for HIV/AIDS Research and Prevention (SCHARP), Seattle, WA, USA.
David D CelentanoDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Apinun AramrattanaResearch Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Annet Davis-VogelDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
David MetzgerDepartment of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.
Carl LatkinDepartment of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 737 Hampton House, Baltimore, MD, 21205, USA. clatkin@jhsph.edu.

Funding

HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUPU01AI046749 · NIAID · FAMILY HEALTH INTERNATIONAL · PI CATES, WILLARD · 1999 to 2005
$73.5M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
HIV PREVENTION TRIALS NETWORK LEADERSHIP GROUPU01AI046702 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FLEMING, THOMAS R · 2000 to 2005
$49.5M
HIV PREVENTION TRIAL UNITU01AI048014 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI METZGER, DAVID S · 2000 to 2006
$20.9M
HIV PREVENTION TRIALS UNIT-THAILANDU01AI047984 · NIAID · JOHNS HOPKINS UNIVERSITY · PI CELENTANO, DAVID D. · 2000 to 2006
$9.7M
A comprehensive approach to secondary HIV prevention and care among positivesR01DA032217 · NIDA · JOHNS HOPKINS UNIVERSITY · PI LATKIN, CARL A · 2011 to 2015
$5.1M
NIAID NIH HHS P30 AI094189NIAID NIH HHS U01 AI046702NIAID NIH HHS U01 AI046749NIAID NIH HHS U01 AI047984NIAID NIH HHS U01 AI048014NIAID NIH HHS U01-AI-46702NIAID NIH HHS U01-AI-46749NIAID NIH HHS U01-AI-47984NIAID NIH HHS U01-AI-48014NIDA NIH HHS R01 DA032217
6 · The paper itself

Abstract

Controlled trials of HIV prevention and care interventions are susceptible to contamination. In a randomized controlled trial of a social network peer education intervention among people who inject drugs and their risk partners in Philadelphia, PA and Chiang Mai, Thailand, we tested a contamination measure based on recall of intervention terms. We assessed the recall of test, negative and positive control terms among intervention and control arm participants and compared the relative odds of recall of test versus negative control terms between study arms. The contamination measures showed good discriminant ability among participants in Chiang Mai. In Philadelphia there was no evidence of contamination and little evidence of diffusion. In Chiang Mai there was strong evidence of diffusion and contamination. Network structure and peer education in Chiang Mai likely led to contamination. Recall of intervention materials can be a useful method to detect contamination in experimental interventions.

Indexed as

Peer GroupRisk Reduction BehaviorAdolescentAdultBiasCross-Cultural ComparisonDrug UsersFemaleHealth EducationHIV InfectionsHumansMaleOutcome and Process Assessment, Health CarePhiladelphiaRisk-TakingSexual PartnersContaminationDiffusionHIVInjection drug usePreventionSocial networks

Identifiers

PMID25935214
PMCPMC4567413

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.